JBC, Vol. 252, Issue 15, 5180-5182, Aug, 1977
Reversible activation of hepatic adenylate cyclase by guanyl-5'-yl-(alpha,beta-methylene)diphosphonate and guanyl-5'-yl imidodiphosphate
C. Londos, M. C. Lin, A. F. Welton, P. M. Lad and M. Rodbell
Guanyl-5'-yl-(alpha,beta-methylene)di[gamma-32P]phosphonate (Gp-(CH2)pp) is
not hydrolyzed by rat liver membranes under conditions in which GTP and
guanyl-5'-yl imidodiphosphate (Gpp(NH)p) are hydrolyzed. Gp(CH2)pp
activates adenylate cyclase in hepatic membranes with characteristics
similar to those of Gpp(NH)p activation but with lower potency and
effectiveness. The analogs, although with lower potency than GTP, also
share the ability to change the glucagon receptor from a high to a low
affinity state. Both Gp(CH2)pp and Gpp(NH)p stimulate adenylate cyclase
activity following a lag period of about 1 min addition of GTP after steady
state rates are achieved results in reduction in the rate following a lag
period of 6 min from the time of addition of GTP. Pretreatment of the
enzyme with Gpp(NH)p or Gp(CH2)pp, followed by washing the membranes, leads
to a high activity state of the enzyme which slowly decays in rate unless
the analogs are continuously present in the medium. These data suggest that
the guanosyl nucleotide analogs act on the enzyme system by a slowly
reversible process that possibly reflects slow binding and dissociation
from different transition states of the enzyme system and suggest that
activation of adenylate cyclase by GTP, Gpp(NH)p, and Gp(CH2)pp does not
involve covalent modification of the enzyme.